{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:24:30Z","timestamp":1789169070241,"version":"build-2803163510"},"reference-count":72,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.3892\/mmr.2017.7831","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T11:07:43Z","timestamp":1508411263000},"page":"9279-9286","source":"Crossref","is-referenced-by-count":46,"title":["Apolipoprotein status in type 2 diabetes mellitus and its complications"],"prefix":"10.3892","volume":"16","author":[{"given":"Puhong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,10,19]]},"reference":[{"key":"key20180108005647_b1-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJMe1607413","article-title":"Cardiac and renovascular complications in type 2 diabetes-is there hope?","volume":"375","author":"Ingelfinger","year":"2016","journal-title":"N Engl J Med"},{"key":"key20180108005647_b2-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMra1011035","article-title":"Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease","volume":"371","author":"Shulman","year":"2014","journal-title":"N Engl J Med"},{"key":"key20180108005647_b3-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1161\/ATVBAHA.109.201715","article-title":"Nonenzymatic glycation impairs the anti-inflammatory properties of apolipoprotein A-I","volume":"30","author":"Nob\u00e9court","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20180108005647_b4-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1042\/CS20120304","article-title":"Small dense LDL is more susceptible to glycation than more buoyant LDL in Type 2 diabetes","volume":"124","author":"Younis","year":"2013","journal-title":"Clin Sci (Lond)"},{"key":"key20180108005647_b5-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/S0140-6736(16)31009-1","article-title":"Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): Two randomised, double-blind, placebo-controlled, dose-ranging trials","volume":"388","author":"Viney","year":"2016","journal-title":"Lancet"},{"key":"key20180108005647_b6-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MOL.0000000000000253","article-title":"Apolipoprotein A-I interactions with insulin secretion and production","volume":"27","author":"Rye","year":"2016","journal-title":"Curr Opin Lipidol"},{"key":"key20180108005647_b7-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1161\/CIRCULATIONAHA.113.001551","article-title":"High-density lipoprotein maintains skeletal muscle function by modulating cellular respiration in mice","volume":"128","author":"Lehti","year":"2013","journal-title":"Circulation"},{"key":"key20180108005647_b8-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1161\/ATVBAHA.110.207373","article-title":"Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion","volume":"30","author":"Fryirs","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20180108005647_b9-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1210\/jc.2009-1402","article-title":"Increased apolipoprotein AI production rate and redistribution of high-density lipoprotein size induced by estrogen plus progestin as oral contraceptive","volume":"94","author":"Duvillard","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180108005647_b10-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1161\/ATVBAHA.115.305777","article-title":"Apolipoprotein A-I limits the negative effect of tumor necrosis factor on lymphangiogenesis","volume":"35","author":"Bisoendial","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20180108005647_b11-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/ATVBAHA.110.222000","article-title":"Lipid-free apolipoprotein A-I and discoidal reconstituted high-density lipoproteins differentially inhibit glucose-induced oxidative stress in human macrophages","volume":"31","author":"Tabet","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20180108005647_b12-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2337\/dc12-1411","article-title":"Glycation of apoprotein A-I is associated with coronary artery plaque progression in type 2 diabetic patients","volume":"36","author":"Pu","year":"2013","journal-title":"Diabetes Care"},{"key":"key20180108005647_b13-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1365-2796.2012.02585.x","article-title":"German Diabetes and Dialysis Study Investigators: Apolipoprotein A-IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus-a post hoc analysis of the 4D Study","volume":"272","author":"Kollerits","year":"2012","journal-title":"J Intern Med"},{"key":"key20180108005647_b14-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00417-011-1855-x","article-title":"Low serum apolipoprotein A1\/B ratio is associated with proliferative diabetic retinopathy in type 2 diabetes","volume":"250","author":"Hu","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key20180108005647_b15-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1194\/jlr.M007815","article-title":"Jejunal wall triglyceride concentration of morbidly obese persons is lower in those with type 2 diabetes mellitus","volume":"51","author":"Soriguer","year":"2010","journal-title":"J Lipid Res"},{"key":"key20180108005647_b16-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1530\/EJE-12-0718","article-title":"Proteomic biomarkers of type 2 diabetes mellitus risk in women with polycystic ovary syndrome","volume":"168","author":"Galazis","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"key20180108005647_b17-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jacl.2012.06.007","article-title":"Apolipoproteins A-I, B, and C-III in young adult Cherokee with metabolic syndrome with or without type 2 diabetes","volume":"7","author":"Wang","year":"2013","journal-title":"J Clin Lipidol"},{"key":"key20180108005647_b18-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1590\/S0100-879X2007000100007","article-title":"Apolipoprotein E polymorphism in Brazilian dyslipidemic individuals: Ouro Preto study","volume":"40","author":"Mendes-Lana","year":"2007","journal-title":"Braz J Med Biol Res"},{"key":"key20180108005647_b19-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cca.2008.04.013","article-title":"Association of APOA5-1131T>C and S19W gene polymorphisms with both mild hypertriglyceridemia and hyperchylomicronemia in type 2 diabetic patients","volume":"394","author":"Charriere","year":"2008","journal-title":"Clin Chim Acta"},{"key":"key20180108005647_b20-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.numecd.2009.04.003","article-title":"The APOA5-1131 T>C variant enhances the association between RBP4 and hypertriglyceridemia in diabetes","volume":"20","author":"Cabr\u00e9","year":"2010","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"key20180108005647_b21-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/dna.2013.2099","article-title":"Association of APOA5-1131T>C polymorphism and serum lipid levels in patients with type 2 diabetes","volume":"32","author":"Celap","year":"2013","journal-title":"DNA Cell Biol"},{"key":"key20180108005647_b22-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"7541","DOI":"10.1007\/s11033-012-1588-x","article-title":"-1131T>C and SW19 polymorphisms in APOA5 gene and lipid levels in type 2 diabetic patients","volume":"39","author":"S\u00f3ter","year":"2012","journal-title":"Mol Biol Rep"},{"key":"key20180108005647_b23-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1007\/s11033-010-0565-5","article-title":"Apolipoprotein A5-1131T>C polymorphism, but not APOE genotypes, increases susceptibility for dyslipidemia in children and adolescents","volume":"38","author":"Brito","year":"2011","journal-title":"Mol Biol Rep"},{"key":"key20180108005647_b24-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2337\/db10-0564","article-title":"Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men","volume":"60","author":"S\u00f8rensen","year":"2011","journal-title":"Diabetes"},{"key":"key20180108005647_b25-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1476-511X-12-54","article-title":"Effect of insulin analog initiation therapy on LDL\/HDL subfraction profile and HDL associated enzymes in type 2 diabetic patients","volume":"12","author":"Aslan","year":"2013","journal-title":"Lipids Health Dis"},{"key":"key20180108005647_b26-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.atherosclerosis.2012.03.033","article-title":"Multiple factors and pathways involved in hepatic very low density lipoprotein-apoB100 overproduction in Otsuka Long-Evans Tokushima Fatty rats","volume":"222","author":"Qin","year":"2012","journal-title":"Atherosclerosis"},{"key":"key20180108005647_b27-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1464-5491.2012.03622.x","article-title":"Increased apoB\/A-I ratio independently associated with Type 2 diabetes mellitus: Cross-sectional study in a Korean population","volume":"29","author":"Hwang","year":"2012","journal-title":"Diabet Med"},{"key":"key20180108005647_b28-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jacl.2012.01.008","article-title":"Non-high-density lipoprotein cholesterol is associated more closely with albuminuria in Chinese type 2 diabetic patients with normal renal function, compared with traditional lipid parameters","volume":"6","author":"Pan","year":"2012","journal-title":"J Clin Lipidol"},{"key":"key20180108005647_b29-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1161\/ATVBAHA.112.255190","article-title":"Retinol-binding protein 4 is an independent factor associated with triglycerides and a determinant of very low-density lipoprotein-apolipoprotein B100 catabolism in type 2 diabetes mellitus","volume":"32","author":"Verg\u00e8s","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20180108005647_b30-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1007\/s00125-010-1806-9","article-title":"FIELD study investigators: Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes","volume":"53","author":"Taskinen","year":"2010","journal-title":"Diabetologia"},{"key":"key20180108005647_b31-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1475-2840-12-55","article-title":"Sagittal abdominal diameter is a more independent measure compared with waist circumference to predict arterial stiffness in subjects with type 2 diabetes-a prospective observational cohort study","volume":"12","author":"Dahl\u00e9n","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"key20180108005647_b32-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.atherosclerosis.2012.01.029","article-title":"Apolipoprotein B-48 as a determinant of endothelial function in obese subjects with type 2 diabetes mellitus: Effect of fenofibrate treatment","volume":"221","author":"Chan","year":"2012","journal-title":"Atherosclerosis"},{"key":"key20180108005647_b33-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00592-012-0434-x","article-title":"Fasting apolipoprotein B48 is a marker for peripheral arterial disease in type 2 diabetes","volume":"50","author":"Mancera-Romero","year":"2013","journal-title":"Acta Diabetol"},{"key":"key20180108005647_b34-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1464-5491.2009.02757.x","article-title":"Parallel increase of plasma apoproteins C-II and C-III in Type 2 diabetic patients","volume":"26","author":"B\u00e9liard","year":"2009","journal-title":"Diabet Med"},{"key":"key20180108005647_b35-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/ATVBAHA.110.220723","article-title":"Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemia","volume":"31","author":"Caron","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20180108005647_b36-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1464-5491.2009.02814.x","article-title":"Serum apolipoprotein C-III in high-density lipoprotein: A key diabetogenic risk factor in Turks","volume":"26","author":"Onat","year":"2009","journal-title":"Diabet Med"},{"key":"key20180108005647_b37-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1161\/01.ATV.0000066131.01313.EB","article-title":"LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients","volume":"23","author":"Lee","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20180108005647_b38-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.2337\/db09-0206","article-title":"ApoCIII-enriched LDL in type 2 diabetes displays altered lipid composition, increased susceptibility for sphingomyelinase, and increased binding to biglycan","volume":"58","author":"Hiukka","year":"2009","journal-title":"Diabetes"},{"key":"key20180108005647_b39-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3132\/dvdr.2007.030","article-title":"The ApoAI-CIII-AIV gene cluster and its relation to lipid levels in type 2 diabetes mellitus and coronary heart disease: Determination of a novel susceptible haplotype","volume":"4","author":"Singh","year":"2007","journal-title":"Diab Vasc Dis Res"},{"key":"key20180108005647_b40-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.clinbiochem.2010.12.009","article-title":"APOC3-482C>T polymorphism, circulating apolipoprotein C-III and smoking: Interrelation and roles in predicting type-2 diabetes and coronary disease","volume":"44","author":"Onat","year":"2011","journal-title":"Clin Biochem"},{"key":"key20180108005647_b41-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s00125-011-2092-x","article-title":"Association of an APOC3 promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons","volume":"54","author":"van Hoek","year":"2011","journal-title":"Diabetologia"},{"key":"key20180108005647_b42-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bbadis.2006.11.008","article-title":"The effect of APOA5 and APOC3 variants on lipid parameters in European Whites, Indian Asians and Afro-Caribbeans with type 2 diabetes","volume":"1772","author":"Dorfmeister","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"key20180108005647_b43-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"e5465","DOI":"10.1371\/journal.pone.0005465","article-title":"Apolipoprotein C3 polymorphisms, cognitive function and diabetes in Caribbean origin Hispanics","volume":"4","author":"Smith","year":"2009","journal-title":"PLoS One"},{"key":"key20180108005647_b44-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/andr.12250","article-title":"Differential expression of apolipoprotein D in male reproductive system of rats by high-fat diet","volume":"4","author":"Lim","year":"2016","journal-title":"Andrology"},{"key":"key20180108005647_b45-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.neurobiolaging.2014.01.148","article-title":"Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain","volume":"35","author":"Dassati","year":"2014","journal-title":"Neurobiol Aging"},{"key":"key20180108005647_b46-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.bbrc.2004.08.146","article-title":"Expression profiling of insulin action in human myotubes: Induction of inflammatory and pro-angiogenic pathways in relationship with glycogen synthesis and type 2 diabetes","volume":"323","author":"Hansen","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108005647_b47-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1464-5491.1994.tb00252.x","article-title":"Apolipoprotein D gene polymorphism: A new genetic marker for type 2 diabetic subjects in Nauru and south India","volume":"11","author":"Baker","year":"1994","journal-title":"Diabet Med"},{"key":"key20180108005647_b48-mmr-16-06-9279","first-page":"568","article-title":"Apolipoprotein-D polymorphism: A genetic marker for obesity and hyperinsulinemia","volume":"79","author":"Vijayaraghavan","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180108005647_b49-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3233\/JAD-160164","article-title":"Clinical response to donepezil in mild and moderate dementia: Relationship to drug plasma concentration and CYP2D6 and APOE genetic polymorphisms","volume":"55","author":"Miranda","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"key20180108005647_b50-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3233\/JAD-160638","article-title":"Effects of tooth loss and the apolipoprotein E \u03b54 Allele on mild memory impairment in the Fujiwara-kyo study of Japan: A Nested Case-Control Study","volume":"55","author":"Okamoto","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"key20180108005647_b51-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ymgme.2010.03.008","article-title":"Apolipoprotein E polymorphisms and type 2 diabetes: A meta-analysis of 30 studies including 5423 cases and 8197 controls","volume":"100","author":"Anthopoulos","year":"2010","journal-title":"Mol Genet Metab"},{"key":"key20180108005647_b52-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/dmrr.616","article-title":"Plasma apolipoprotein E concentration is an important determinant of phospholipid transfer protein activity in type 2 diabetes mellitus","volume":"22","author":"Tan","year":"2006","journal-title":"Diabetes Metab Res Rev"},{"key":"key20180108005647_b53-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3109\/0886022X.2011.568133","article-title":"Association of the angiotensinogen M235T and APO E gene polymorphisms in Turkish type 2 diabetic patients with and without nephropathy","volume":"33","author":"Reis","year":"2011","journal-title":"Ren Fail"},{"key":"key20180108005647_b54-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/0003319712453645","article-title":"The \u03b54 allele of the APOE gene is associated with more severe peripheral neuropathy in type 2 diabetic patients","volume":"64","author":"Monastiriotis","year":"2013","journal-title":"Angiology"},{"key":"key20180108005647_b55-mmr-16-06-9279","first-page":"385","article-title":"Association between apolipoprotein E-polymorphism and Ischemic heart disease patients with or without type 2 diabetes mellitus: A preliminary study in Kuwait","volume":"14","author":"Al-Majed","year":"2011","journal-title":"Arch Iran Med"},{"key":"key20180108005647_b56-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s11033-009-9666-4","article-title":"Butyrylcholinesterase K variant and the APOE-\u03b54 allele work in synergy to increase the risk of coronary artery disease especially in diabetic patients","volume":"37","author":"Vaisi-Raygani","year":"2010","journal-title":"Mol Biol Rep"},{"key":"key20180108005647_b57-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1475-2840-11-36","article-title":"Apolipoprotein E gene polymorphism: Effects on plasma lipids and risk of type 2 diabetes and coronary artery disease","volume":"11","author":"Chaudhary","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"key20180108005647_b58-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.atherosclerosis.2009.06.036","article-title":"Apolipoprotein E genotype predicts cardiovascular endpoints in dialysis patients with type 2 diabetes mellitus","volume":"208","author":"Winkler","year":"2010","journal-title":"Atherosclerosis"},{"key":"key20180108005647_b59-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/archneurol.2007.29","article-title":"Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: The Cardiovascular Health Study Cognition Study","volume":"65","author":"Irie","year":"2008","journal-title":"Arch Neurol"},{"key":"key20180108005647_b60-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1007\/s00125-009-1497-2","article-title":"Presence of the APOE epsilon4 allele modifies the relationship between type 2 diabetes and cognitive performance: The Maine-Syracuse Study","volume":"52","author":"Dore","year":"2009","journal-title":"Diabetologia"},{"key":"key20180108005647_b61-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"71817","DOI":"10.18632\/oncotarget.12376","article-title":"Chronic low-dose-rate ionising radiation affects the hippocampal phosphoproteome in the ApoE-\/-Alzheimer's mouse model","volume":"7","author":"Kempf","year":"2016","journal-title":"Oncotarget"},{"key":"key20180108005647_b62-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12944-016-0325-1","article-title":"Effects of hyperlipidaemia on plasma apolipoprotein M levels in patients with type 2 diabetes mellitus: An independent case-control study","volume":"15","author":"Zhang","year":"2016","journal-title":"Lipids Health Dis"},{"key":"key20180108005647_b63-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"30655","DOI":"10.1038\/srep30655","article-title":"Binding Characteristics of Sphingosine-1-Phosphate to ApoM hints to assisted release mechanism via the ApoM Calyx-opening","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"key":"key20180108005647_b64-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.atherosclerosis.2009.11.024","article-title":"Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese men","volume":"210","author":"Ooi","year":"2010","journal-title":"Atherosclerosis"},{"key":"key20180108005647_b65-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1074\/jbc.M114.596445","article-title":"LDL receptor and ApoE are involved in the clearance of ApoM-associated sphingosine 1-phosphate","volume":"290","author":"Kurano","year":"2015","journal-title":"J Biol Chem"},{"key":"key20180108005647_b66-mmr-16-06-9279","first-page":"796","article-title":"Reduced expression and secretion of apolipoprotein M in fat-fed, streptozotocin-diabetic rats is partially reversed by an artificial ligand of PPAR\u03b3","volume":"37","author":"Qu","year":"2012","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"key20180108005647_b67-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12944-016-0307-3","article-title":"A single-nucleotide polymorphism C-724\/del in the proter region of the apolipoprotein M gene is associated with type 2 diabetes mellitus","volume":"15","author":"Zhang","year":"2016","journal-title":"Lipids Health Dis"},{"key":"key20180108005647_b68-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cca.2017.01.006","article-title":"ApoM\/HDL-C and apoM\/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus","volume":"466","author":"Zhang","year":"2017","journal-title":"Clin Chim Acta"},{"key":"key20180108005647_b69-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/dmrr.641","article-title":"Single nucleotide polymorphisms in the proximal promoter region of apolipoprotein M gene (apoM) confer the susceptibility to development of type 2 diabetes in Han Chinese","volume":"23","author":"Niu","year":"2007","journal-title":"Diabetes Metab Res Rev"},{"key":"key20180108005647_b70-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1476-511X-12-135","article-title":"Apolipoprotein M T-778C polymorphism is associated with serum lipid levels and the risk of coronary artery disease in the Chinese population: A meta-analysis","volume":"12","author":"Zhang","year":"2013","journal-title":"Lipids Health Dis"},{"key":"key20180108005647_b71-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"e17324","DOI":"10.1371\/journal.pone.0017324","article-title":"Apolipoprotein M gene (APOM) polymorphism modifies metabolic and disease traits in type 2 diabetes","volume":"6","author":"Zhou","year":"2011","journal-title":"PLoS One"},{"key":"key20180108005647_b72-mmr-16-06-9279","doi-asserted-by":"crossref","first-page":"371","DOI":"10.12659\/MSM.893077","article-title":"Functional study of \u2212724I\/D polymorphism in apolipoprotein M (apoM) gene promoter region and its association with myocardial infarction","volume":"21","author":"Guo","year":"2015","journal-title":"Med Sci Monit"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T21:56:46Z","timestamp":1570226206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2017.7831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,19]]},"references-count":72,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,10,19]]},"published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.3892\/mmr.2017.7831"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2017.7831","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,19]]}}}